Unraveling the Complex Interplay between Epigenetics and Immunity in Alcohol-Associated Liver Disease: A Comprehensive Review

被引:6
|
作者
Liu, Yali [1 ]
Liu, Tao [1 ]
Zhang, Feiyu [1 ]
Gao, Yanhang [1 ]
机构
[1] Jilin Univ, First Hosp Jilin Univ, Dept Hepatol, Changchun 130021, Jilin, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
alcohol-associated liver disease; immune microenvironment; epigenetic modifications; exosomes; cytokines and chemokines; S-ADENOSYLMETHIONINE; DNA METHYLATION; HISTONE H3; METHIONINE ADENOSYLTRANSFERASE; EXTRACELLULAR VESICLES; CELL ACTIVATION; ACETYLATION; ETHANOL; STRESS; INJURY;
D O I
10.7150/ijbs.87975
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms of immune dysfunction in alcohol-associated liver disease (ALD) have garnered growing research interest in recent times. Alcohol-mediated immune dysfunction has been implicated as a potential cause of ALD-associated microbial infection and inflammatory response. The immune microenvironment of an organism is essentially a complex network of interactions between immune cells, cytokines, extracellular matrix, and other immune-related molecules. This microenvironment is highly adaptive and responsive to environmental cues. Epigenetic reprogramming of the immune microenvironment has recently emerged as a key driver of ALD progression, particularly in the context of endotoxin tolerance and immune disorders. Although epigenetic modifications are known to play an important role in the regulation of the immune microenvironment in ALD, the specific mechanisms and molecular processes by which this regulation is achieved are yet to be fully understood. This paper aims to provide an overview of the current knowledge on the effects of alcohol consumption on epigenetics, with special focus on summarizing the data on the epigenetic regulatory mechanisms involved in the effects of alcohol consumption on the immune microenvironment. In addition, this paper aims to present a review of the epigenetic modifications involved in different forms of ALD. This review is expected to offer new perspectives for the diagnosis, treatment, monitoring, and prognostic assessment of ALD from an epigenetic perspective.
引用
收藏
页码:4811 / 4830
页数:20
相关论文
共 50 条
  • [21] The lymphatic system in alcohol-associated liver disease
    Kondo, Reiichiro
    Iwakiri, Yasuko
    CLINICAL AND MOLECULAR HEPATOLOGY, 2020, 26 (04) : 633 - 638
  • [22] Advances in the management of alcohol-associated liver disease
    Anouti, Ahmad
    Kerr, Thomas A.
    Mitchell, Mack C.
    Cotter, Thomas G.
    GASTROENTEROLOGY REPORT, 2024, 12
  • [23] Dietary cholesterol in alcohol-associated liver disease
    Jia, Lin
    IMMUNOMETABOLISM, 2023, 5 (02) : E00026
  • [24] Rifaximin-α in alcohol-associated liver disease
    Xie, Chencheng
    Singal, Ashwani K.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (06): : 495 - 497
  • [25] Gut Microbiome and Alcohol-associated Liver Disease
    Philips, Cyriac A.
    Schnabl, Bernd
    Bajaj, Jasmohan S.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (05) : 1349 - 1359
  • [26] Inflammation in alcohol-associated liver disease progression
    Lotersztajn, Sophie
    Riva, Antonio
    Wang, Sai
    Dooley, Steven
    Chokshi, Shilpa
    Gao, Bin
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (01): : 58 - 66
  • [27] Complement System in Alcohol-Associated Liver Disease
    Santiesteban-Lores, Lazara Elena
    Carneiro, Milena Carvalho
    Isaac, Lourdes
    Bavia, Lorena
    IMMUNOLOGY LETTERS, 2021, 236 : 37 - 50
  • [28] Advancements in the Alcohol-Associated Liver Disease Model
    Zhu, Lin
    Li, Hai-Di
    Xu, Jie-Jie
    Li, Juan-Juan
    Cheng, Miao
    Meng, Xiao-Ming
    Huang, Cheng
    Li, Jun
    BIOMOLECULES, 2022, 12 (08)
  • [29] The role of SELENOF in alcohol-associated liver disease
    Boedeker, K.
    Qiu., W.
    ALCOHOL, 2024, 121
  • [30] Activation of HSCs in alcohol-associated liver disease
    Kisseleva, T.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 83 - 83